Radium-223 for men with hormone-refractory prostate cancer and bone metastases

被引：6
|
作者：
Shelley, Mike D. [1 ]
Mason, Malcolm D.
机构：
[1] Velindre NHS Trust, Cochrane Urol Canc Unit, Cardiff CF14 2TL, Wales
[2] Velindre NHS Trust, Dept Oncol, Cardiff CF14 2TL, Wales
来源：
LANCET ONCOLOGY | 2007年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(07)70180-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [21] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [22] Radium-223 dichloride in patients with castration-refractory prostate cancer
    Winter, B. M.
    von Rundstedt, F. -C.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (11): : 1435 - 1439
  • [23] Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
    Lam, Marnix G. E. H.
    Zonnenberg, Bernard A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (07) : 1394 - 1395
  • [24] Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
    Hijab, Adham
    Curcean, Sebastian
    Tunariu, Nina
    Tovey, Holly
    Alonzi, Roberto
    Staffurth, John
    Blackledge, Matthew
    Padhani, Anwar
    Tree, Alison
    Stidwill, Helen
    Finch, Jessica
    Chatfield, Peter
    Perry, Sophie
    Koh, Dow Mu
    Hall, Emma
    Parker, Chris
    CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : E299 - E305
  • [25] Mechanistic Modeling of Radium-223 Treatment of Bone Metastases
    Moreira, Hugo M. R.
    Guerra Liberal, Francisco D. C.
    O'Sullivan, Joe M.
    McMahon, Stephen J.
    Prise, Kevin M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1221 - 1230
  • [26] Therapy of bone metastases with radium-223 German guidelines
    Poeppel, Thorsten D.
    Andreeff, Michael
    Becherer, Alexander
    Bockisch, Andreas
    Fricke, Eva
    Geworski, Lilli
    Heinzel, Alexander
    Krause, Bernd J.
    Krause, Thomas
    Mitterhauser, Markus
    Scheidhauer, Klemens
    Schenck, Marcus
    Sonnenschein, Wilfried
    Gabriel, Michael
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (05): : 177 - 186
  • [27] Radium-223 as an Approved Modality for Treatment of Bone Metastases
    Brito, Ana Emilia
    Etchebehere, Elba
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (02) : 177 - 192
  • [28] Investigation of the safety of Radium-223 chloride in combination with external beam radiotherapy for bone metastases of prostate cancer
    Makino, Soichi
    Miyazawa, Kazunari
    Katsuoka, Yoji
    Ooe, Takeru
    Aikawa, Ken
    Segawa, Akira
    Kobayashi, Hiroshi
    JOURNAL OF RADIATION RESEARCH, 2025,
  • [29] Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
    Wakita, Naoto
    Hara, Takuto
    Suzuki, Kotaro
    Terakawa, Tomoaki
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    ANTICANCER RESEARCH, 2024, 44 (06) : 2627 - 2635
  • [30] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
    Curley, Tracy
    Arauz, Gabrielle
    Jensen, Trine
    Wahba, Mona
    Delacruz, Anthony
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
12345